8Kong DJ, YW, Wang ZW, et al. The miR-200 regulates PDGF-D mediated epithelial-mesenchymal transition, adhesion and invasion of prostate cancer ceils [ J ]. Stem Cells, 2009,27 ( 8 ) : 1712-1721.
9Eitner F, Bticher E, van Roeyen C, et al. PDGF-C is a proinflam- matory cytokine that mediates renal Interstitial fibrosis [ J ]. J Am Soc Nephrol, 2008,19 (2) :281-289.
10Sabuda-Widemann D, Grabensee B, Schwandt C, et al. Mycophe- nolic acid inhibits the autocrine PDGF-B synthesis and PDGF-BB- induced mRNA expression of Egr-1 in rat mesangial cells [ J ]. Nephrol Dial Transplant,2009,24( 1 ) :52-61.
6FLOEGE J,OSTENDORF T,WOLF G.Growth factors and cytokines.In:Immunologic Renal Disease[M],second,edited by Neilson EG,Couser WG.Philadelphia,Lippincott-Raven,2001,pp415-463.
7FLOEGE J,HUDKINS KL,SEIFERT RA,et al.Localization of PDGF alpha-receptor in the developing and mature human kidney[J].Kidney Int,1997,51(4):1140-1150.
8ROBYN G.LANGHAM,DARREN J.KELLY,JULIE MAGUIRE.Over-expression of platelet-derived growth factor in human diabetic nephropathy[J].Nephrol Dial Transplant,2003,18:1392-1396.
9RANIERI E,GESUALDO L,GRANDALIANO G,et al.The role of alpha-smooth muscle actin and platelet-derived growth factor-beta receptor in the progression of renal damage in human IgA nephropathy[J].J Nephrol,2001,14(4):253-262.
10TAKAHIKO NAKAGAWA,MASAKIYO SASAHARA,MASAKAZU HANEDA,et al.Role of PDGF B-Chain and PDGF receptors in rat tubular regeneration after acute injury[J].Am J Pathol.1999,155(5):1689-1699.
3Mori H,Okada Y,Arao T,et al.Sitagliptin improves albuminuria in patients with type 2diabetes mellitus[J].J Diabetes Investig,2014,5(3):313-319.
4Mega Cristina,Teixeira de Lemos Edite,Vala Helena,et al.Diabetic nephropathy amelioration by a low-dose sitagliptin in an animal model of type 2diabetes(zucker diabetic fatty rat)[J].Experimental Diabetes Research,2011,2011:1-12.
5Kodera R,Shikata K,Takatsuka T,et al.Dipeptidyl peptidase-4inhibitor ameliorates early renal injury through its anti-inflammatory action in a rat model of type 1diabetes[J].Biochem Biophys Res Commun,2014,443(3):828-833.
6Li J,Guan M,Li C,et al.The dipeptidyl peptidase-4inhibitor sitagliptin protects against dyslipidemia-related kidney injury in Apolipoprotein E knockout mice[J].Int J Mol Sci,2014,15(7):11416-11434.
7Weir MR,Hollenberg NK,Remuzzi G,et al.Varying patterns of the antihypertensive and antialbuminuric response to higher doses of renin-angiotensin-aldosterone system blockade in albuminuric hypertensive type 2diabetes mellitus patients[J].J Hypertens,2011,29(10):2031-2037.
8Yang W,Chen L,Ji Q,et al.Liraglutide provides similar glycaemic control as glimepiride(both in combination with metformin)and reduces body weight and systolic blood pressure in Asian population with type 2diabetes from China,South Korea and India:a 16-week,randomized,double-blind,active control trial[J].Diabetes Obes Metab,2011,13(1):81-88.
9Kawasaki I,Hiura Y,Tamai A,et al.Sitagliptin reduces the urine albumin-to-creatinine ratio in type 2diabetes through decreasing both blood pressure and estimated glomerular filtration rate[J].J Diabetes,2015,7(1):41-46.
10Frazier KS,Paredes A,Dube P,et al.Connective tissue growth factor expression in the rat remnant kidney model and association with tubular epithelial cells undergoing transdifferentiation[J].Vet Pathol,2000,37(4):328-335.
